(18 June 2025, Hong Kong) – SMOORE International Holdings Limited (“SMOORE” or the “Company”, together with its subsidiaries, the “Group”, Stock Code: 6969.HK), the world’s leading atomization product manufacturer, today announced the approval of the validation of its near-term science-based targets by the Science Based Targets initiative (SBTi). This achievement positions SMOORE as one of the corporate in the electronic atomization industry to establish Science Based Targets and receive the approval of SBTi validation.

October 21, 2024 – Today, MOYAL, an innovative skincare brand focused on transforming how skincare products are delivered and absorbed, proudly announces its launch in the United States. Available exclusively at www.MoyalBeauty.com, MOYAL is introducing a patent-pending skincare atomization device that allows serums to penetrate deeper into the skin than ever before—without invasive treatments or harmful side effects.

On the late night of April 25th Beijing time, the first round table forum of the Global Tobacco & Nicotine Forum (GTNF) held in London.

Smoore International Holdings Limited (Smoore) secured the top position among global electronic atomization companies.

September 2022 – Smoore Technology participated in a meeting with the United States Food and Drug Administration (FDA)

SMOORE Academic Workshop was successfully hold on November 14th, 2020.

SMOORE International Holdings Co., Ltd., and the Tongji University team have received approval after jointly applying for a research project from the National Natural Science Foundation of China.

A New York federal judge recently granted Shenzhen Smoore Technology Limited (belonging to Smoore International Holdings Limited, hereinafter referred to as "Smoore", stock code: 6969.HK), the company behind the globally recognized Vaporesso e-cigarette brands, a $5.4 million default judgment and permanent injunction against over 100 defendants accused of selling Vaporesso and other Smoore's self-branded counterfeit goods.

On September 1, 2020, the local time in the U.S., according to the PMTA audit receipt provided by the U.S. Food and Drug Administration (hereinafter referred to as "FDA"), SMOORE International Holdings Co., Ltd. (hereinafter referred to as "SMOORE") own brand VAPORESSO has become the first vaping brand in the industry to complete the filing stage of PMTA review. The announcement indicates that VAPORESSO’s first batch products submitted to the FDA, with their high-quality, have quickly passed the first two rounds of rigorous review. Meanwhile, completing the filing stage also represents that products of VAPORESSO have entered the final stage of the PMTA application process.

The world’s biggest maker of vaping device has shrugged off the challenges of coronavirus, the US-China trade war and tougher regulations to report a huge increase in profit.

On December 19, 2019, SMOORE submitted the listing application materials to the Hong Kong Stock Exchange in the name of the holding company SMOORE International Holdings Limited. At 9:30 am on July 10, 2020, SMOORE International (6969.HK) was officially listed on the Hong Kong Stock Exchange.

On July 10th, Smoore International Holdings Limited (Smoore for short) officially listed on HKEX (Hongkong Exchanges and Clearing Limited), stock code 6969.HK. Its initial IPO price was12.4HKD, while the closing price reached 31 HKD and market value 178 billion HKD.